ICU Medical, Inc. (ICUI) Receives Average Rating of “Hold” from Brokerages

ICU Medical, Inc. (NASDAQ:ICUI) has been given a consensus recommendation of “Hold” by the six brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has given a buy recommendation to the company.

A number of brokerages have issued reports on ICUI. Zacks Investment Research downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Friday, July 14th. BidaskClub downgraded ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. KeyCorp began coverage on ICU Medical in a research note on Tuesday. They issued a “sector weight” rating for the company. Finally, Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th.

In related news, Director Robert S. Swinney sold 463 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the completion of the sale, the director now directly owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Vivek Jain sold 2,205 shares of the firm’s stock in a transaction dated Tuesday, October 10th. The stock was sold at an average price of $190.91, for a total value of $420,956.55. The disclosure for this sale can be found here. Insiders have sold a total of 22,452 shares of company stock valued at $4,127,838 over the last three months. Corporate insiders own 13.60% of the company’s stock.

Large investors have recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after purchasing an additional 66 shares during the last quarter. Riverhead Capital Management LLC increased its position in shares of ICU Medical by 99.8% during the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of ICU Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 157 shares during the last quarter. Parametrica Management Ltd acquired a new stake in shares of ICU Medical during the 2nd quarter worth about $213,000. Finally, Teacher Retirement System of Texas acquired a new stake in shares of ICU Medical during the 2nd quarter worth about $214,000. 78.13% of the stock is owned by hedge funds and other institutional investors.

WARNING: “ICU Medical, Inc. (ICUI) Receives Average Rating of “Hold” from Brokerages” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://ledgergazette.com/2017/10/20/icu-medical-inc-icui-receives-average-rating-of-hold-from-brokerages.html.

ICU Medical (NASDAQ ICUI) traded up 1.53% on Tuesday, reaching $192.70. 115,653 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $183.96 and a 200 day moving average price of $169.55. The firm has a market cap of $3.82 billion, a PE ratio of 77.17 and a beta of 0.35. ICU Medical has a one year low of $127.00 and a one year high of $193.23.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. During the same period last year, the business earned $1.15 earnings per share. The firm’s revenue was up 242.8% compared to the same quarter last year. On average, equities analysts anticipate that ICU Medical will post $4.11 earnings per share for the current year.

A number of brokerages have issued reports on ICUI. Zacks Investment Research downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Friday, July 14th. BidaskClub downgraded ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. KeyCorp began coverage on ICU Medical in a research note on Tuesday. They issued a “sector weight” rating for the company. Finally, Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th.

In related news, Director Robert S. Swinney sold 463 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the completion of the sale, the director now directly owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Vivek Jain sold 2,205 shares of the firm’s stock in a transaction dated Tuesday, October 10th. The stock was sold at an average price of $190.91, for a total value of $420,956.55. The disclosure for this sale can be found here. Insiders have sold a total of 22,452 shares of company stock valued at $4,127,838 over the last three months. Corporate insiders own 13.60% of the company’s stock.

Large investors have recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after purchasing an additional 66 shares during the last quarter. Riverhead Capital Management LLC increased its position in shares of ICU Medical by 99.8% during the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of ICU Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 157 shares during the last quarter. Parametrica Management Ltd acquired a new stake in shares of ICU Medical during the 2nd quarter worth about $213,000. Finally, Teacher Retirement System of Texas acquired a new stake in shares of ICU Medical during the 2nd quarter worth about $214,000. 78.13% of the stock is owned by hedge funds and other institutional investors.

WARNING: “ICU Medical, Inc. (ICUI) Receives Average Rating of “Hold” from Brokerages” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://ledgergazette.com/2017/10/20/icu-medical-inc-icui-receives-average-rating-of-hold-from-brokerages.html.

ICU Medical (NASDAQ ICUI) traded up 1.53% on Tuesday, reaching $192.70. 115,653 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $183.96 and a 200 day moving average price of $169.55. The firm has a market cap of $3.82 billion, a PE ratio of 77.17 and a beta of 0.35. ICU Medical has a one year low of $127.00 and a one year high of $193.23.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. During the same period last year, the business earned $1.15 earnings per share. The firm’s revenue was up 242.8% compared to the same quarter last year. On average, equities analysts anticipate that ICU Medical will post $4.11 earnings per share for the current year.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.